{"id":"W4386282331","doi":"10.1016/s2152-2650(23)01457-x","title":"MM-493 Progression-Free Survival of Daratumumab vs Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients: TAURUS Chart Review Study","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Lenalidomide; Daratumumab; Bortezomib; Dexamethasone; Multiple myeloma; Medicine; Oncology; Internal medicine; Progression-free survival; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001418682,0.0001857741,0.0007460379,0.0007471218,0.000316548,0.0008837323,0.0003998888,0.000323962,0.002064119],"category_scores_gemma":[0.002359977,0.0001749667,0.001047705,0.001773534,0.0002289686,0.0004233493,0.0002539587,0.0003532702,0.0003192286],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001620402,"about_ca_system_score_gemma":0.001612874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005513563,"about_ca_topic_score_gemma":0.01033348,"domain_scores_codex":[0.9991834,0.0003175746,0.0001153676,0.0001603909,0.000154571,0.00006863809],"domain_scores_gemma":[0.9975618,0.0005795126,0.001239032,0.0001460895,0.0003105151,0.0001631286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2236642,0.001384622,0.5642725,0.00944841,0.009666967,0.0007042875,0.0008167144,0.0009968471,0.005874167,0.000828608,0.01349473,0.168848],"study_design_scores_gemma":[0.02489573,0.01317033,0.9237713,0.001496275,0.01147563,0.0007747863,0.0004788404,0.0006031303,0.002016461,0.0001476582,0.02108663,0.00008326608],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9416822,0.04554095,0.0002115098,0.0003370269,0.00008758034,0.0003411153,0.008595191,0.00002713198,0.003177319],"genre_scores_gemma":[0.9822783,0.01084147,0.0003865621,0.0002852837,0.00008571782,0.0002050683,0.005119031,0.00001249301,0.0007860673],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005513563,"threshold_uncertainty_score":0.01175684,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04190971868810255,"score_gpt":0.3558880232178257,"score_spread":0.3139783045297231,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}